The no-touch vein harvesting technique significantly lowers the risk of graft failure for up to three years after coronary ...

No-touch' vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass ...

No-touch’ vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass ...

No-touch’ vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass surgery compared with conventionally harvested vein grafts, finds a study from ...

No-touch' vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass surgery compared with ...

Learn more about whether Glaukos Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether LeMaitre Vascular, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

lower extremity joint replacement, surgical hip femur fracture treatment, spinal fusion, coronary artery bypass graft, and major bowel procedure. TEAM is designed to reduce some of the $47.6 ...

biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded ...

“In patients with coronary artery disease, or CAD, stronger quadriceps are linked to significantly lower risk of both ... syndrome or coronary artery bypass grafting. Over an average follow ...